Cory Kasimov
Stock Analyst at Evercore ISI
Total Price Targets
24
Stocks Covered
13
Sectors
Healthcare
Most Recent
Feb 26, 2026
Notable Calls (Last 12 Months)
Most Bullish
Stocks Covered by Cory Kasimov
| Symbol | Company | Latest Target | Current Price | Upside | # Targets | Last Updated |
|---|---|---|---|---|---|---|
| EWTX | Edgewise Therapeutics, Inc. | $45.00 | $30.63 | +46.9% | 1 | Feb 26, 2026 |
| VIR | Vir Biotechnology, Inc. | $18.00 | $10.02 | +79.7% | 1 | Feb 24, 2026 |
| ACLX | Arcellx, Inc. | $115.00 | $115.07 | -0.1% | 3 | Feb 23, 2026 |
| MRNA | Moderna, Inc. | $35.00 | $44.65 | -21.6% | 5 | Feb 17, 2026 |
| VRTX | Vertex Pharmaceuticals Incorporated | $530.00 | $425.06 | +24.7% | 2 | Jan 23, 2026 |
| CYTK | Cytokinetics, Incorporated | $80.00 | $64.40 | +24.2% | 1 | Sep 3, 2025 |
| REGN | Regeneron Pharmaceuticals, Inc. | $1170.00 | $703.72 | +66.3% | 4 | Oct 31, 2024 |
| BMRN | BioMarin Pharmaceutical Inc. | $115.00 | $54.20 | +112.2% | 2 | Aug 6, 2024 |
| NBIX | Neurocrine Biosciences, Inc. | $175.00 | $131.64 | +32.9% | 1 | May 13, 2024 |
| BBIO | BridgeBio Pharma, Inc. | $50.00 | $69.25 | -27.8% | 1 | May 13, 2024 |
| BIIB | Biogen Inc. | $236.00 | $186.69 | +26.4% | 1 | Feb 3, 2022 |
| ACAD | ACADIA Pharmaceuticals Inc. | $34.00 | $21.95 | +54.9% | 1 | Aug 4, 2021 |
| GILD | Gilead Sciences, Inc. | $74.00 | $132.04 | -44.0% | 1 | Apr 29, 2021 |
Recent Activity
- Feb 26, 2026— Set$45.00price target onEWTX(Edgewise Therapeutics, Inc.)
- Feb 24, 2026— Set$18.00price target onVIR(Vir Biotechnology, Inc.)
- Feb 23, 2026— Set$115.00price target onACLX(Arcellx, Inc.)
- Feb 17, 2026— Set$35.00price target onMRNA(Moderna, Inc.)
- Jan 23, 2026— Set$530.00price target onVRTX(Vertex Pharmaceuticals Incorporated)
- Sep 3, 2025— Set$80.00price target onCYTK(Cytokinetics, Incorporated)
- Aug 1, 2025— Set$32.00price target onMRNA(Moderna, Inc.)
- Oct 31, 2024— Set$1170.00price target onREGN(Regeneron Pharmaceuticals, Inc.)
- Oct 29, 2024— Set$120.00price target onACLX(Arcellx, Inc.)
- Oct 24, 2024— Set$1175.00price target onREGN(Regeneron Pharmaceuticals, Inc.)
- Sep 12, 2024— Set$105.00price target onMRNA(Moderna, Inc.)
- Aug 6, 2024— Set$115.00price target onBMRN(BioMarin Pharmaceutical Inc.)
- May 13, 2024— Set$120.00price target onMRNA(Moderna, Inc.)
- May 13, 2024— Set$85.00price target onACLX(Arcellx, Inc.)
- May 13, 2024— Set$50.00price target onBBIO(BridgeBio Pharma, Inc.)
- May 13, 2024— Set$113.00price target onBMRN(BioMarin Pharmaceutical Inc.)
- May 13, 2024— Set$175.00price target onNBIX(Neurocrine Biosciences, Inc.)
- May 13, 2024— Set$1150.00price target onREGN(Regeneron Pharmaceuticals, Inc.)
- Feb 4, 2022— Set$604.00price target onREGN(Regeneron Pharmaceuticals, Inc.)
- Feb 3, 2022— Set$236.00price target onBIIB(Biogen Inc.)
Frequently Asked Questions
Who is Cory Kasimov?
Cory Kasimov is a stock analyst at Evercore ISI covering 13 stocks primarily in Healthcare. They have issued 24 price targets since Apr 29, 2021.
What stocks does Cory Kasimov cover?
Cory Kasimov currently covers 13 stocks, including MRNA, REGN, ACLX, VRTX, BMRN.
What is Cory Kasimov's latest price target?
Cory Kasimov's most recent price target was $45.00 on EWTX (Edgewise Therapeutics, Inc.), set on Feb 26, 2026.
What is Cory Kasimov's highest price target?
Cory Kasimov's highest issued price target is $1175.00 on REGN, set on Oct 24, 2024.
More Analysts at Evercore ISI
Coverage based on publicly published price targets. Not investment advice.